Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Understanding when most people start planning for retirement can help you avoid delays. Find out the trends and best practices for timely planning.
22,030 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Quantum computing promises a new tech frontier, but today's stock prices often reflect dreams more than cash flow. Th...
Affirm stock has caught investors' attention as it swings between growth bets and risk concerns. This guide breaks do...
With $1,000 in hand, your goal is steady income and growing wealth. This guide shows how to identify the ultimate div...
Here Tuesday’s Wall Street roundup highlights fresh analyst calls across airlines, energy and software as markets nav...
Intel kicked off a high-volume enterprise processor launch, lifting the stock as investors weigh the company’s path b...
Solana SOL faces a pivotal test as the $90 floor flips to a ceiling while trading volume wanes. Analysts warn that th...
Oil ETFs have soared 100% plus this year, underscoring a powerful rebound in crude. This report breaks down what’s dr...
XRP sits in a tight range around $1.40 as analysts map the path to a potential break all-time high this year. The out...
Rocket Lab rockets higher after a record Q1 FY2026 showing strong revenue and a bloated backlog, signaling momentum f...
XRP sits around $1.40 as institutions quietly expand tokenized-asset settlements on public rails, even as on-chain ac...
Institutional investors are pouring money back into XRP ETFs, driving inflows to a five-month high. Analysts say this...